Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.03.2023 | Case report

Denosumab

Hungry bone syndrome, hypocalcaemia and rebound effect in the form of hypercalcaemia: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Pal R, et al. Comment on "Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer": Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget's Disease of Bone. Osteoporosis International 33 : 2227-2228, No. 10, Oct 2022. Available from: URL: http://doi.org/10.1007/s00198-022-06443-6 Pal R, et al. Comment on "Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer": Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget's Disease of Bone. Osteoporosis International 33 : 2227-2228, No. 10, Oct 2022. Available from: URL: http://​doi.​org/​10.​1007/​s00198-022-06443-6
Metadaten
Titel
Denosumab
Hungry bone syndrome, hypocalcaemia and rebound effect in the form of hypercalcaemia: case report
Publikationsdatum
01.03.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-36146-2

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Methadone

Case report

Fluorouracil

Case report

Amiodarone

Case report

Multiple drugs

Case report

Agalsidase-β